NEW YORK (GenomeWeb) – Natera reported after the close of the market on Thursday that its third quarter 2018 revenues rose 17 percent.

The San Carlos, California molecular diagnostics firm reported total revenues of $65.3 million, up from $55.9 million in Q3 2017, but missing analysts average estimate of $66.4 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Sponsored by
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.


This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.